Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter

Radioiodine therapy, the most effective form of systemic radiotherapy available, is currently useful only for thyroid cancer because of the thyroid-specific expression of the human sodium iodide symporter (hNIS). Here, we explore the efficacy of a novel form of gene therapy using prostate-specific m...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiao-Feng, Zhou, Tie, Chen, Guang-Hua, Xu, Chuan-Liang, Ding, Ye-Lei, Sun, Ying-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901869/
https://www.ncbi.nlm.nih.gov/pubmed/24369144
http://dx.doi.org/10.4103/1008-682X.122354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901869/
https://www.ncbi.nlm.nih.gov/pubmed/24369144
http://dx.doi.org/10.4103/1008-682X.122354

Ejemplares similares